课题基金 / 基金详情

FUNCTIONAL ANALYSIS OF THE TANGIER DISEASE GENE ABC1

FUNCTIONAL ANALYSIS OF THE TANGIER DISEASE GENE ABC1
丹吉尔病基因 ABC1 的功能分析
批准号:
6402737
负责人:
MICHAEL Leo FITZGERALD
金额:
$4.94万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
未结题
起止时间:
2001-08-23 至

项目摘要

项目成果

MICHAEL Leo FITZGERALD的其他基金

相似基金

相关文献

中文摘要
翻译
在西方社会,心血管疾病是导致死亡的主要原因。升高的循环高密度脂蛋白(HDL)水平被认为通过介导胆固醇转运出外周组织来防止疾病状态。然而,这一过程背后的分子机制尚未完全表征。最近发现的丹吉尔病基因产物(ABC1),当在人类中发生突变时,会导致循环HDL下降到无法检测的水平,这为逆向胆固醇运输过程提供了额外的分子见解。这一应用提出了ABC1在细胞定位方面的结构-功能分析,ABC1的蛋白质-蛋白质分子描述与HDL动员细胞内胆固醇酯储存的能力有关,将有助于开发心血管疾病的新疗法。
英文摘要
Cardiovascular disease is the leading cause of mortality in western societies. Increased levels of circulating high-density lipoproteins (HDL) are thought to protect against the disease state by mediating cholesterol transport out of peripheral tissues. However, the molecular mechanisms underlying this process are incompletely characterized. The recent identification of the Tangier disease gene product (ABC1), which when mutated in human causes circulating HDL to drop to undetectable levels, has provided additional molecular insight into the process of reverse cholesterol transport. This application proposes to a structure-function analysis of ABC1 in terms of its cellular localization, protein-protein molecular description of ABC1 in relation to the ability of HDL to mobilize intracellular stores of cholesterol-esters will be helpful in the development of novel therapies for cardiovascular disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Epigenetic Reprogramming in Atherosclerosis
Epigenetic Reprogramming in Atherosclerosis
HDL prevention of cholesterol crystal inflammation in HIV disease
  • 批准号:
    8884627
  • 项目类别:
  • 资助金额:
    $60.29万
  • 财政年份:
    2012
  • 负责人:
    MICHAEL Leo FITZGERALD
  • 依托单位:
HDL prevention of cholesterol crystal inflammation in HIV disease
  • 批准号:
    8221304
  • 项目类别:
  • 资助金额:
    $64.68万
  • 财政年份:
    2012
  • 负责人:
    MICHAEL Leo FITZGERALD
  • 依托单位:
海外基金